Fuso Chemical (4368) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
24 Mar, 2026Executive summary
Net sales for the three months ended June 30, 2025, rose 7.0% year-over-year to ¥18,658 million, with operating profit up 20.0% to ¥4,694 million and profit attributable to owners of parent up 7.6% to ¥3,105 million.
Comprehensive income declined 27.7% year-over-year to ¥2,731 million, reflecting negative foreign currency translation adjustments.
Financial highlights
Gross profit increased to ¥7,213 million from ¥6,242 million year-over-year.
Operating profit margin improved, with operating profit at ¥4,694 million versus ¥3,910 million a year earlier.
Earnings per share for the quarter were ¥88.07, up from ¥81.83 year-over-year.
Total assets decreased to ¥137,154 million as of June 30, 2025, from ¥141,502 million at March 31, 2025.
Net assets increased to ¥105,448 million from ¥104,048 million at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecasted at ¥72,700 million, up 4.6% year-over-year, with operating profit expected to reach ¥13,800 million (16.7% increase).
Profit attributable to owners of parent projected at ¥9,400 million for the full year, a 19.1% increase year-over-year.
Earnings per share forecasted at ¥266.61 for the full year.
Dividend forecast maintained at ¥76.00 per share for the year ending March 31, 2026.
Latest events from Fuso Chemical
- Double-digit sales and profit growth in Q1, with upwardly revised full-year outlook.4368
Q1 202524 Mar 2026 - Record half-year profit and sales growth driven by semiconductors, but FX hit comprehensive income.4368
Q2 202524 Mar 2026 - Record-high sales and profits, with next year’s guidance projecting lower earnings but higher dividends.4368
Q4 202524 Mar 2026 - Strong year-over-year growth in sales and profits, with robust outlook for the full year.4368
Q3 202524 Mar 2026 - Record-high sales and profits with strong outlook, led by semiconductor demand and expansion.4368
Q2 202624 Mar 2026 - Strong year-over-year growth in sales, profits, and margins with a positive full-year outlook.4368
Q3 202624 Mar 2026